Exchange Announcement • 26 Dec 2023 19:12
Exchange Announcement • 19 Dec 2023 07:46
Exchange Announcement • 19 Dec 2023 06:25
Exchange Announcement • 16 Dec 2023 07:55
Exchange Announcement • 16 Dec 2023 07:46
ENTITY
Seagen (SGEN US)
Seagen (SGEN US)
40
Analysis
Health Care • United States
Seagen Inc. operates as a biotechnology company. The Company discovers and develops monoclonal antibody-based drugs to treat cancer and related diseases, as well as offers antibody-drug conjugate technology designed to deliver cell-killing agents directly to tumor cells. Seagen serves customers worldwide.
more
x